The Global Adrenogenital Syndrome Treatment Industry is on a trajectory of substantial growth, set to achieve a robust 5.6% Compound Annual Growth Rate (CAGR) from 2023 to 2033, reaching an estimated US$ 12.81 billion in 2023. This forecast, highlighted in a comprehensive report by [Your Company/Organization], underscores the rising demand for effective treatments in the …